Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

Professor George Obeng Adjei, Director, Centre for Tropical Pharmacology and Therapeutics, University of Ghana Medical School, says clinical trials ...

The 64-year-old counts himself lucky he had access to life saving treatment brought to his backyard by TrialHub – a ...

ONCOMATRYX, a biopharmaceutical company developing novel ADCs against the tumor microenvironment, has successfully raised €25 million, to fund Phase Ib-II clinical trials of OMTX705, a first-in-class ...

AMB-066 is a potential first-in-class treatment for CRC MRD ~20,000 patients diagnosed annually in U.S.; no currently ...

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

For generations, Native peoples have been pioneers in medicine, carefully testing traditional healing practices to benefit ...

Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.

The integration of Artificial Intelligence (AI) into the medical field marks a groundbreaking shift, with expectations that ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

One of GPT-4’s key strengths lies in its ability to extract explicit and straightforward information from medical notes. The ...

Akero Therapeutics’ impressive performance in both stock price and clinical trials has made it a stock to watch in 2025. With a promising treatment on the horizon and significant gains to show for it, ...